Dopamine Agonist Therapy in the Management of a Prolactinoma

December 23, 2023by Dr. S. F. Czar0

Case Study: 

Patient Profile:Dopamine

  • Name: Sarah
  • Age: 32
  • Gender: Female
  • Occupation: Marketing Manager
  • Chief Complaint: Irregular menstrual periods, breast milk production, and headaches

Presenting Symptoms:

Sarah presents to her endocrinologist with concerns about irregular menstrual periods, breast milk production despite not being pregnant or breastfeeding, and persistent headaches. She has also noticed changes in her vision, with episodes of double vision and peripheral visual field deficits.

Medical History:

  • Sarah has no significant prior medical conditions or surgeries.
  • She is not taking any medications or supplements.

Physical Examination:

  • Physical examination reveals no significant abnormalities in vital signs.
  • The endocrinologist observes galactorrhea (spontaneous discharge of milk from the breast) during the examination.
  • Visual field testing indicates bitemporal hemianopia (a visual field defect affecting peripheral vision).

Diagnostic Tests: Dopamine

Based on Sarah’s symptoms and physical examination findings, the following diagnostic tests are ordered:

  • Blood Tests:
    • Blood tests reveal elevated levels of prolactin (hyperprolactinemia), consistent with excess prolactin production.
    • Other hormone levels, including thyroid function, are within normal limits.
  • Magnetic Resonance Imaging (MRI):
    • An MRI of the brain is performed to assess the pituitary gland. The imaging shows a pituitary adenoma, measuring approximately 1.5 cm in diameter, consistent with a prolactinoma.


Sarah is diagnosed with a prolactinoma, a type of pituitary tumor that produces excessive amounts of prolactin, leading to her symptoms of irregular menstrual periods, breast milk production, headaches, and visual field deficits.

Treatment Plan:

Sarah’s treatment plan involves addressing the prolactinoma and its associated hormonal effects:

  • Dopamine Agonist Therapy:
    • Sarah is started on a dopamine agonist medication, in this case, cabergoline, to suppress the overproduction of prolactin by the tumor.
    • The endocrinologist explains the importance of medication adherence and regular follow-up appointments to monitor hormone levels and assess treatment response.
  • Ophthalmological Consultation:
    • Sarah is referred to an ophthalmologist for further evaluation and management of her visual field deficits.
    • The ophthalmologist recommends close monitoring of her vision and discusses potential surgical interventions if necessary.


  • Over the next few months, Sarah’s prolactin levels gradually decrease, and her symptoms of irregular menstrual periods and breast milk production improve.
  • Her headaches become less frequent and less severe.
  • Visual field testing shows stabilization and slight improvement in her peripheral vision.
  • Sarah continues dopamine agonist therapy and regular follow-up appointments to ensure the tumor’s response to treatment and monitor any potential side effects.


This case study illustrates the effective use of dopamine agonist therapy, specifically cabergoline, in the management of prolactinoma. Prolactinomas are the most common type of functioning pituitary tumors, and their symptoms are often related to the excessive production of prolactin.

Dopamine agonists, such as cabergoline, are the primary treatment choice for prolactinomas due to their ability to inhibit prolactin secretion by acting on dopamine receptors in the pituitary gland. They effectively reduce prolactin levels, alleviating symptoms such as irregular menstrual periods, galactorrhea, and headaches.

The case also highlights the importance of multidisciplinary care. Sarah’s referral to an ophthalmologist is crucial for managing her visual field deficits, a potential complication of larger pituitary tumors. Regular follow-up appointments and ongoing monitoring are essential to assess treatment response and ensure that her prolactinoma remains well-controlled.

In conclusion, dopamine agonist therapy has revolutionized the management of prolactinomas, offering effective control of hormonal imbalances and associated symptoms. This case study emphasizes the significance of early diagnosis, appropriate treatment initiation, and coordinated care to optimize outcomes for patients with pituitary tumors like Sarah.


Leave a Reply

Your email address will not be published. Required fields are marked *

© 2023. All rights reserved.